Aveanna Healthcare Updates Stockholders Agreement and Board

Tip Ranks
2025.11.14 22:08
portai
I'm PortAI, I can summarize articles.

Aveanna Healthcare Holdings amended its Stockholders Agreement on November 13, 2025, restricting certain executives from transferring common stock without pre-approval, while allowing other stockholders to transfer shares freely. Christopher Gordon resigned as a Class II director, and Sam Weil from Bain Capital was appointed to the board. The most recent analyst rating on AVAH stock is a Hold with a $10.00 price target. AVAH's financial performance shows strong revenue and EBITDA growth but is constrained by high leverage and negative equity.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Aveanna Healthcare Holdings ( (AVAH) ) has provided an update.

On November 13, 2025, Aveanna Healthcare Holdings Inc. amended its Stockholders Agreement, restricting certain executives from transferring common stock without pre-approval, while allowing other stockholders to transfer shares freely. Additionally, Christopher Gordon resigned as a Class II director, and Sam Weil, a Principal at Bain Capital, was appointed to fill the vacancy, bringing his expertise in healthcare investments to the board.

The most recent analyst rating on (AVAH) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Aveanna Healthcare Holdings stock, see the AVAH Stock Forecast page.

Spark’s Take on AVAH Stock

According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.

Aveanna Healthcare Holdings’ overall score is primarily influenced by its strong earnings call performance, indicating robust revenue and EBITDA growth. However, financial performance is constrained by high leverage and negative equity, and valuation concerns arise from a high P/E ratio. Technical indicators show a positive trend, but valuation remains a significant risk.

To see Spark’s full report on AVAH stock, click here.

More about Aveanna Healthcare Holdings

Aveanna Healthcare Holdings Inc. operates in the healthcare industry, focusing on healthcare delivery and life sciences. The company collaborates with private equity firms like Bain Capital and J.H. Whitney Capital Partners.

Average Trading Volume: 1,473,375

Technical Sentiment Signal: Buy

Current Market Cap: $1.84B

For an in-depth examination of AVAH stock, go to TipRanks’ Overview page.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.